Topic: Libido

Research into GLP-1 weight loss medications like Ozempic suggests potential side effects including decreased libido and sexual dysfunction. The hosts discuss how these drugs affect dopamine reward pathways in the brain, potentially contributing to the declining U.S. birth rate. The segment explores the irony of medications intended to make users more attractive simultaneously reducing their desire for intimacy.

A report from a salon in Austin, Texas, suggests a significant cultural shift among liberal women, characterized by a decline in sexual activity and rising cancer rates. These health trends are attributed to increased cortisol levels, immune suppression, and the over-prescription of antidepressants, which are known to negatively impact libido. Local data indicates the birth rate in Austin has significantly decreased as a result of these social and medical factors.

A discussion regarding testosterone replacement therapy (TRT) explores its perceived benefits for physical daring and professional sales performance. One host recounts a personal history of using prescribed testosterone and its effects on libido and confidence during business negotiations. The conversation references Joe Rogan's public use of similar treatments.

A lighthearted report suggests Ozempic may increase libido as a side effect. The show concludes with a final round of donor acknowledgments, including Greg Hoy and Michael Henry. The hosts emphasize the importance of the "Value for Value" model as overall donations have seen a decline.

A "boots on the ground" report explores the link between SSRI-induced sexual dysfunction and the "sissy hypnosis" porn subculture. The theory suggests that young men unable to achieve orgasm through traditional means are groomed into "forced feminization" fetishes. The hosts analyze an Instagram video from a "sissy coach" who uses subtle signs to convince men they are inherently feminine.

A CNN report claims that global warming is negatively impacting human sex drives and birth rates in the United States. Researchers suggest that temperatures over 80 degrees lead to fewer births nine months later, potentially resulting in 100,000 fewer births annually. The hosts question the logic of the study and the editorial standards of the network.

The approval of Addyi, the "little pink pill" for female sexual dysfunction, is linked to the widespread use of SSRI antidepressants. A producer's personal story illustrates how antidepressants can eliminate sexual desire, creating a secondary market for drugs intended to restore libido.